Serum Insulin-Like Growth Factor-1 and Nitric Oxide Levels in Parkinson's Disease

Table 2

Nitric oxide, growth hormone, insulin-like growth factor-1, and insulin-like growth factor BP-3 levels of the patients with PD and healthy controls.

	Patients	Controls
Nitric oxide (𝜇mol/L)
mean±SD	2.3±0,4	2.8±0.6^∗
Growth hormone (ng/mL)
mean±SD	0.9±0.9	0.7±1.2
Insulin-like growth factor-1 (ng/mL)
(mean±SD)	132±42	113±51
Insulin-like growth factor BP-3 (𝜇g/mL)
(mean±SD)	3.4±0.8	3.7±1

^∗𝑃:.011, P:.52, P:.087, P:.19, respectively.